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ver the past two decades, stem cell research has advanced 
our understanding of key aspects of organogenesis through 
the exploitation of the self-organizing properties of adult 
stem cells (ASCs) and pluripotent stem cells (PSCs). Such progresses 
have led to the development of cell culture procedures to generate 
micro- and miniorgan-like structures on demand, the so-called 
organoids. In parallel, the emergence of the bioengineering field 
is leading to technological advances that allow proper instructive 
environments (physical and chemical), boosting cellular responses 
towards the formation of organ-specific multicellular structures 
in these miniorgan-like structures. Current methods rely on tra-
ditional three-dimensional (3D) culture techniques that exploit 
cell-autonomous self-organization of human PSCs (hPSCs) (Fig. 1). 
Nevertheless, hPSC-derived organoids still exhibit several short-
comings. These

 include the lack of reproducibility; lack of specific-
ity with regard to cell-type(s) composition; uncontrolled size; shape 
heterogeneity; absence of proper vascular, immune and innervation 
components and organ-specific morphological features; and lack 
of functionality. Therefore, major goals of organoid technology are 
now focused on improving organoids cellular and morphological 
complexity (for example, via the induction of properly organized 
regional identities in brain organoids, or providing a developing 
branching collecting-duct system in kidney organoids), providing 
perfusable vascular networks (to facilitate organoid differentiation 
and lifespan, but also organoid-to-organoid connection for studying 
complex interactions between different tissue types), and enhanc-
ing organoid maturation in order to achieve relevant tissue-specific 
functionalities. Understanding and integrating self-formation 
capacities and programmability of hPSCs with bioengineering 
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design may increase control of self-organization and functionality of 
hPSC-derived organoids. This knowledge will help the community 
to generate higher-grade organoids (in terms of cellular composi-
tion, architecture, function and reproducibility) for developmental 
biology, drug screening, disease modelling and personalized/precise 
medicine applications, and in the future to derive clinically relevant 
tissue-like structures for regenerative medicine applications (Fig. 1).

In this Review, we first look back on the historical origin of 
organoid technology and how early developments in 3D cell cul-
ture systems exploiting the self-organization ability of hPSCs have 
enabled generation of these powerful platforms. We will collectively 
examine how to apply current knowledge in organoid mechanics 
and transcriptomics to further control the arrangement function 
and composition of hPSC-derived organoids. Then, we foresee the 
immediate impact of engineering approaches (that is, biomimetic 
hydrogels, 3D bioprinting and microtechnologies) to overcome 
current hPSC-derived organoids challenges in the upcoming years. 
Finally, we will discuss on how ethicists, engineers and stem cell 
biologists will need to collaborate on engineering ethics and how 





 some text here.
Evolution of 3D cultures in the organoid’s history. Since the 
1900s, developmental biologists have selected different model 
organisms to study the morphogenetic processes occurring dur-
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ics. This Review underlines the need for providing engineering solutions to gain control of self-organization and functionality 
of hPSC-derived organoids. We expect that this knowledge will guide the community to generate higher-grade hPSC-derived 
organoids for further applications in developmental biology, drug screening, disease modelling and personalized medicine.
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chick and mice. All

 these different systems have contributed sub-
stantially to address key long-standing questions in this field. 
Groundbreaking observations performed in these organisms dur-
ing the first decades of the last century highlighted the intrinsic 
capacities of tissues to follow predetermined developmental and 
functional programmes and how these dictated the mutual and 
exclusive relations between cells during reaggregation (Box 1). By

 
the 1940s, different researchers demonstrated that growing tissue 
removed from the avian limb rudiment would rearrange and pat-
tern in vitro and in ovo1,2. In addition, disaggregated and reaggre-
gated chick embryonic kidneys became proper kidney epithelial 
tubules surrounded by mesenchyme-derived stroma in culture3. 
These experiments pinpointed that cell reaggregation could result 
in self-reassembly of tissue-like structures, whereby cells organized 
autonomously into pre-patterned structures. Paul Weiss and A. 
Cecil Taylor showed that when chick embryonic cells from differ-
ent organs at advanced stages of development were reaggregated 
and grafted into a highly vascularized ‘neutral environment’, as the 
chick chorioallantoic membrane (CAM), the resulting ‘cell masses’ 
formed well-organized organs ex vivo4. Interestingly, in that study 
the authors highlighted the phenomenon of self-organization as the 
major cause driving morphogenesis instead of ‘external inductions’, 
which was the major trend explaining development at that time4. 
Q7
Q8
By contrast, experiments by Clifford Grobstein demonstrated that 
when an inducing source, such as spinal cord, was reaggregated 
with the kidney metanephric mesenchyme, nephron-like structures 
were able to develop in vitro5.
As the knowledge of 3D cultures progressed, intense research 
was devoted to explore how the extracellular matrix (ECM) dic-
tates morphogenesis and function in a wide range of cell cultures6. 
Later, Hans Clevers and colleagues applied this knowledge to cul-
ture single-cell suspensions of Lgr5+ mouse intestinal stem cells 
embedded in Matrigel under specific culture conditions succeeding 
in the generation of intestinal organoids with a crypt-villus architec-
ture7. This seminal study and others facilitated the development of 
ASC-derived organoids, such as stomach, pancreas, colon, prostate 
and liver. Progress in ASC-derived organoids and major advances in 
this field have recently been addressed in several excellent reviews8,9.
Since the isolation of human embryonic stem cells (ESCs) in 
199810 and the reprogramming of human somatic cells into induced 
pluripotent stem cells (iPSCs)11, both sources have become instru-
mental in recapitulating the fundamental principles of tissue differ-
entiation and morphogenesis. Because PSCs represent the starting 
point of differentiation (pluripotency stage), they offer a model of 
organ ontogeny and a ‘minimal system’ for discerning in a systematic 
manner the relative contribution of different cellular components to 
Establishment 
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• Increase organoid lifespan
• Provide proper vascularization
• Achieve relevant tissufic architecture and functionality 
Bioengineering ethics
• Informed consent requirements for procuring human cells
• Development of ethical guidelines for organoid research
Novel ethical issues include:
• Biobanking and research sharing of organoids
• Potential role of organoids in personalized medicine
• Impact of organoids on animal research and clinical trials
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Fig. 1 | Advances in engineering hPSC-derived organoids. Timeline of milestones for the generation of organoids from hPSCs. To date, several engineering 
solutions controlling self-organization, differentiation and tissue boundary conditions have explored micropatterning and microfluidics to improve organoid 
outcomes. Other approaches aiming to gain control on cell-to-cell and cell-to-ECM are considered when fabricating new materials emulating biochemical 
or biophysical properties of native tissues. These biomimetic materials can be further exploited for 3D bioprinting creating better tissue architectures. 
The application of these engineering approaches together with emergent technologies from the fields of transcriptomics and mechanics are expected 
to provide a better control of hPSC organoid generation. At the same time, the ethical dimension in this field compromises policies for patient consent, 
biobanking or animal use. All these considerations call for responsibility in communicating results to the public and the need to discuss these topics 
between ethicists, engineers and stem cell biologists.
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complex morphogenetic processes. Profiting from extensive knowl-
edge accumulated from mouse development and mouse PSCs, 
research studies employ (extrapolated) growth signalling molecules 
to instruct hPSC differentiation in two-dimensional (2D) condi-
tions or generating hPSC aggregate-like structures named embry-
oid bodies (EBs). This knowledge was key for obtaining for the first 
time self-patterned stratified cortical tissue after plating EBs gener-
ated in serum-free medium on a coated surface12. Later Sasai and 
colleagues maintained EBs as floating neuroepithelial cysts with 
minimal exogenously provided signals (Matrigel)13, which further 
self-organized into optic cup organoids containing spatially sepa-
rated domains of neural retina and retinal pigmented epithelium. 
Building on this, further studies using spontaneous differentiation 
generated brain organoids with a wide variety of regional identi-
ties14,15, while more directed approaches with small molecules 
could generate specific brain regions16,17. A common feature of the 
various methods developed for hPSC-derived neural organoids is 
that the factors that are applied to the cells attempt to reproduce 
the in vivo signalling networks and associated timing to which the 
rudimentary organ is exposed during development. Similarly, other 
hPSC-derived organoids seek to mimic these developmental events 
to generate tissues that mimic the in  vivo counterparts. This has 
now been quite successful for kidney18, intestine19, lung20 and inner 
ear21, to name a few.
Understanding self-organization and symmetry breaking. For an 
aggregate of cells (PSCs or committed organ progenitors) to evolve 
from a simple spheroid to an organoid with complex tissue architec-
ture, symmetry breaking must occur. While the precise mechanisms 
that underlie this process are in most cases still unclear, in general 
it involves a certain degree of stochastic differentiation, cell sorting 
and feedback between neighbouring cells to set up boundaries and 
signalling centres22. This spontaneous organization probably results 
from stochastic fate acquisition, followed by cell rearrangements in 
which cells with similar adhesive properties tend to associate with 
one another23.
This type of symmetry breaking continues throughout devel-
opment, both in vivo and in vitro. As cells of the same germ layer 
accumulate in segregated compartments often lined by basement 
membranes of ECM, they too generate (and respond to) signalling 
patterns, resulting in symmetry breaking to start forming specific 
substructures that will develop into the various organ precursors. 
Similarly, anterior–posterior symmetry breaking has also been 
shown in the so-called mouse gastruloids, which are essentially 
mouse EBs exposed to a short pulse of Wnt stimulation24,25. These 
aggregates do not epithelialize or cavitate like in vivo pre-gastrulating 
mouse embryos, but spontaneously develop a localized patch of 
Brachyury-positive cells, indicating a process like primitive streak 
formation. Importantly, the vast majority of gastruloids forms only 
one such patch, pointing to feedback between cells to develop and 
elongate along one axis, similar to in vivo26.
Once symmetry breaking has occurred, further signalling events 
from specialized regions called signalling centres help to further 
pattern and set up organ topography. For example, in the devel-
oping brain, dorsal and ventral signalling centres in the roof plate 
and floor plate signal through Wnt/Bmp and Shh pattern adjacent 
progenitors and influence their fate27. Interestingly, floor plate sig-
nalling centres have been shown to spontaneously form in neural 
tube organoids with a pulse of retinoic acid28. Likewise, the fore-
brain dorsal signalling centre, called the hem, has been shown to 
spontaneously form in brain organoids29. These signalling centres 
are necessary for proper tissue architecture and for the formation 
of boundary regions that separate functionally distinct units such 
as the choroid plexus, which generates the cerebrospinal fluid, and 
the cerebral cortex.
Finally, once organ or tissue progenitors are specified and take 
on a specific regional identity, their intrinsic architecture can fur-
ther shape the tissue and force asymmetric structures. In the (small) 
intestine, the position of intestinal stem cells within the crypt means 
that more differentiated daughter cells are forced up into the villi, 
which of course is important for proper functioning of the (small) 
intestine30. Similarly, neural stem cells called radial glia in the devel-
oping brain have an elongated shape that extends from the inter-
nal brain ventricles to the outer surface. Because their cell bodies 
take up the internal ventricular zone entirely, more differentiated 
daughter cells are forced up, and in fact use the elongated basal pro-
cesses of the radial glia to migrate out into the cortical plate31. This 
positioning is important for proper architecture of the grey matter 
and formation of the white matter, an organization that also dictates 
proper connectivity and functioning of the brain.
Bioengineering strategies to enhance complexity. The deriva-
tion of hPSC organoids mainly relies on the self-organization 
principle with minimal control over the external inputs supplied 
to the system. At the same time, the uncontrolled nature of these 
processes contributes to the high heterogeneity observed in the 
current organoid systems, which results in low reproducibility of 
hPSC differentiation among different laboratories32, the variability 
in the differentiation outcomes between distinct hPSC lines, and 
inter-experimental variation33. Engineering-controlled microen-
vironments by the presentation of both chemical (that is, growth 
factors and integrin-binding proteins) and physical instructions 
(applied forces, elastic modulus, geometry and Poisson’s ratio of 
matrix) represent affordable approaches towards the programmabil-
ity of these cues for a better control of organoid self-organization and 
differentiation.
Box 1 | Evolution of 3D cultures in the organoid’s history
Reviewing

 the origin of organoids brings to mind an assay writ-
ten by Henry Van Peters Wilson in 1907 entitled ‘On some phe-
nomena of coalescence and regeneration in s

ponge’100. Current 
key issues in the organoid field were already highlighted in his 
words: “In a recent communication I described some degen-
erative and regenerative phenomena in sponges and pointed 
out that a knowledge of these powers made it possible for us to 
grow sponges in a new way. The gist of the matter is that silicious 
sponges when kept in confinement under proper conditions de-
generate in such a manner that while the bulk of the sponge dies, 
the cells in certain regions become aggregated to form lumps of 
undifferentiated tissue”. H. V. Wilson refers to current concepts 
such as growing cells and tissues as “a new way” and stresses the 
need to define “proper conditions” to accomplish this goal. Later, 
in 1906, Ross G. Harrison pioneered the hanging drop culture 
system to study the origin of nerve cells by culturing fragments 
of frog embryonic nerves in a drop of lymph on a coverslip101. 
This approach allowed the direct observation of a growing nerve 
“while alive”, setting the basis for other experiments culturing 
tissues of different embryonic origins for prolonged periods of 
time. By the 1950s, collective efforts led to the development of 
methods sustaining the culture of tissue fragments (through the 
watch glass method by Strangeways and Fell, 1926)102 and or-
gan slides (through the lens paper method by Trowell, 1954)103. 
By the 1980s, the community had acquired technical skills and 
knowledge of ECM biology to continue exploring 3D cultures, a 
key feature to enable organoid culture. Among the first examples 
of what today might be considered an organoid is the work of 
Streuli and Bissell that pioneered the development of 3D mam-
mary gland cultures104. Slight modifications of some of these 3D 
culture methods are nowadays applied to organoids14,18.
Q9
Q10
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Engineering self-organization. During numerous developmental 
processes, gradients of relevant morphogens and physical cues 
continuously help to establish both the polarity and the diver-
sity in the structures that emerge in vivo. In the same manner, in 
self-organizing organoid systems, successive local microenviron-
ment modifications rapidly promote the emergence of complex 
cellular patterns, further driving organoid morphogenesis in vitro. 
Nevertheless, the control of these morphogenetic processes in 
self-organizing organoids can be solely achieved through externally 
imposing biochemical and biophysical boundaries to the system. 
Therefore, engineering approaches to control the initial cellular 
density, geometry/shape and size of cell aggregates, cell–ECM inter-
actions and biochemical gradients would provide more accurate 
instructions for hPSC-derived organoids generation. Conversely, 
these strategies may also be exploited when aiming to alter the path 
of development to achieve a different outcome.
Micropatterning techniques have been used to control physi-
cal boundary conditions by the creation of confined 2D patterns 
with defined geometry and size in culture substrates. Using this 
2D approach, hPSCs cultured in confined circular patterns in the 
presence of BMP4, generated a concentric pattern of cells from the 
different germ layers, the so-called human gastruloids34,35. Similarly, 
cardiac micro-tissues have been reproducibly induced by seeding 
hPSCs in circular patterns36. These studies revealed that the syn-
ergy between biochemical cues and biophysical cell confinement for 
directing cell fate responses tightly depends on pattern geometry 
and size (Fig. 2a).
In vivo, ECM dynamics can delineate tissue boundaries guiding 
tissue morphogenesis37. For example, ECM remodelling has been 
shown to play an essential role during branching morphogenesis, 
a key developmental process that dictates the functional archi-
tecture of organs such as the lung, kidney (ureteric bud), mam-
mary gland and salivary gland (submandibular gland)37. Although 
ECM mechanical properties dictate cell behaviours such as pro-
liferation and differentiation38, only a few studies have explored 
the use of synthetic materials emulating in vivo ECM for guiding 
hPSC-derived organoid formation39–41 (Fig. 2b,c). Of note, whereas 
most natural ECMs are nonlinear and viscoelastic42, many synthetic 
matrices are not. These characteristics and their effect on organoid 
self-organization remain under investigation.
A powerful approach for creating complex biomolecule gra-
dients is the use of microfluidic technology. In a recent study a 
microfluidic device was used to generate orthogonal gradients of 
retinoic acid and smoothened agonist (a small molecule activator 
of the sonic hedgehog (SHH) pathway), either simultaneously or 
sequentially, that allowed the derivation of motor neurons from 
mouse ESC-derived EBs by emulating in vivo neural tube pattern-
ing43. More recently, a microfluidic device was designed to expose 
hPSC colonies to spatiotemporally controlled morphogen gradi-
ents generated from artificial signalling centres that promoted the 
generation of different axially arranged differentiation domains 
in 2D hPSC cultures44 (Fig. 2d). Soon, these approaches could be 
further advanced to control size and geometry of 3D cultures and 
their exposure to controlled morphogen gradients, which repre-
sents an additional layer of complexity yet to be overcome. In this 
regard, an elegant study implemented a 3D co-culture strategy for 
mimicking a developmental organizer, which consisted in the 3D 
co-culture of small clusters of hPSCs producing SHH protein gra-
dients together with wild-type hPSCs. This resulted in the genera-
tion of polarized SHH-patterned forebrain organoids that displayed 
distinct in vivo-like forebrain domains45 (Fig. 2e). Alternatively, the 
modulation of biochemical signalling in space and time could be 
achieved using dynamic hydrogel systems that change their chemi-
cal and mechanical properties over time due to light-triggered reac-
tions. Soluble biomolecules would be locally tethered in a target 
area within the hydrogel network in a reversible manner, permitting 
the fabrication of very precise 3D patterns and gradients of bio-
chemical cues that are dynamically controlled upon light expo-
sure46. These types of hydrogels could be useful to locally guide 
organoid self-organization (that is, by locally softening or stiffening 
of the matrix47, and even to create stiffness gradients48). However, 
further research is needed to fulfil the potential of this approaches 
in the organoid field.
Transcriptomics and tissue mechanics. The convergence of organ-
oid technology with emergent transcriptomics and tissue mechan-
ics techniques offer unprecedented opportunities to study human 
development and tissue morphogenesis as well as new prospects 
for personalized and precise medicine applications. To date most 
organoids (and organs) have been profiled or sequenced in bulk 
during the process of differentiation, but the field is moving rapidly 
towards a more in-depth knowledge of the cellular composition of 
organoids (and organs)49. In addition, the increased availability of 
organ-specific datasets together with the use of machine learning 
algorithms (that is, artificial intelligence) is making it possible to 
predict accurately the identity score of cell types present in organ-
oids. One example of such algorithms is KeyGenes (http://www.key-
genes.nl)50, which has been used to predict the proximity of kidney 
organoids to human fetal kidneys showing differentiation progres-
sion in time towards second trimester kidneys18,40. The dynamics of 
the molecular signalling pathways and tissue-specific transcription 
factors needed for each developmental transition in  vivo is being 
revealed51,52. In parallel, other technologies are also being developed 
to integrate positional information on top of genome-wide informa-
tion such as in  situ sequencing and high-multiplex imaging mass 
cytometry53. These new technologies will be useful to associate 
positional information to cellular signatures and states within the 
organoid. When used at different time points during organoid for-
mation these procedures have the potential to define a biochemical 
signature for each cell within the organoid. Furthermore, assessing 
differential responses in front of environmental or genetic manipu-
lations during organoid ontogeny will also be important for captur-
ing disease phenotype(s) (Fig. 3).
In vivo, a complex combination of genetic programmes and mul-
tiple types of microenvironmental cues instruct the shaping of tis-
sues and organs during development. These interactions control a 
set of mechanical processes such as deformation, remodelling and 
flow, that ultimately shape the organ54. Our current understand-
ing of the mechanics of morphogenesis has largely been obtained 
through top-down approaches, whereby the mechanisms that lead 
to shape changes can be deconstructed, for example, in whole 
embryos through a combination of imaging, genetic manipula-
tions, and force inference methods54,55. While the relevance of these 
approaches is clear, using embryos has the drawback of limited 
accessibility in terms of imaging and mechano-chemical manipu-
lation. In contrast, hPSC-derived organoids represent an afford-
able in  vitro model for assessing both the mechanical aspects of 
human tissue morphogenesis and the impact of these processes 
during disease. In parallel with the development of tools to probe 
organoid mechanics (Box  2), the advance of computational tools 
and models that support mechanical measurements to predict 
and direct morphogenesis is crucial. To date, different model sys-
tems have been developed to explain the dynamics of flat epithe-
lial monolayers, including lattice, phase fields, active network, 
particle and continuum models. Their application to three dimen-
sions has already resulted in some successes56,57. These simulations 
can be used to study how cell-generated forces can give rise to 
folded epithelial shapes within organoids58. Indeed, very recently 
Karzbrun and colleagues have explored a similar approach to 
model the physics of the folding in the appearance of wrinkles dur-
ing the in vitro development and self-organization of human brain 
organoids59 (Fig. 3).
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Overall, coupling transcriptional information and mechanical 
signatures of cells within the organoid in time and space will pro-
vide a precise description of the organoid dynamics and the emer-
gence of tissue functionality during organoid ontogeny as well as in 
response to different environmental stimuli or genetic manipula-
tions for studying human development and disease.
Bioengineering strategies to enhance maturation and function. 
Current organoid methodologies have allowed the formation of rel-
atively complex tissue-like structures of limited lifespan and func-
tionality. Importantly, the possibility to couple these approaches 
using patient specific iPSCs60,61 or through CRISPR/Cas9-mediated 
gene editing in founder hPSCs59,62 or in the time course of organoid 
differentiation63,64 has started to show the utility of these systems 
for disease modelling applications. The final realization of these 
systems imposes the development of engineering approaches to 
provide the necessary nutritional and gas exchange needs to allow 
increase in size, lifespan, complexity and maturation. While these 
strategies may offer the possibility to generate larger scale tissues 
from organoids, it may also allow different tissue types to connect 
for example via the embedding of vasculature.
Engineering vascularization. In most organoid culture systems, nutri-
ent and gas exchange is achieved by passive diffusion via the culture 
media, thus limiting the cell aggregate size to ~1 mm to prevent the 




















































































































































Fig. 2 | Engineering approaches to guide hPSC-derived organoids self-organization. a, Geometry and size of 2D patterns generated on substrates by 
micropatterning techniques have proved to influence hPSC self-organization and commitment into small cardiac like-structures through the generation 
of diffusible biochemical gradients and local mechanical cues. b, Strategies promoting cell–cell and cell–ECM interactions can also be applied to better 
direct hPSC-organoids differentiation. For example, the use of polyacrylamide hydrogels mimicking a soft microenvironment mechanically instructed the 
derivation of hPSC-renal progenitors (intermediate mesoderm) in a 2D setting, which after aggregation, showed higher potential to give rise to kidney 
organoids compared with rigid conditions. c, The use of micro-structured poly(lactic-co-glycolic) acid (PLGA) scaffolds induced the formation of brain 
organoids with an elongated shape that regionalized into different forebrain regions and further showed the development of aligned neurons, forming a 
pseudo-cortical plate structure. d, Other strategies involve incorporating mechanical and topographical cues in combination with biochemical signalling. 
The use of microfluidics for culturing size-controlled hPSC colonies generated precise morphogen gradients that instruct hPSC differentiation into different 
axially organized germ layer domains. e, 3D morphogen gradients were successfully generated through the co-culture of small clusters of genetically 
modified hPSCs that express SHH in an inducible manner, which upon aggregation together with wild type hPSCs, formed cell spheroids that polarized and 
further resulted into brain organoids with in vivo-like dorsal–ventral and anterior–posterior forebrain regions. In the next years strategies supporting the 
external control of biophysical and biochemical cues to guide hPSCs self-organization are expected to contribute to standardize hPSC organoid derivation. 
Figure reproduced with permission from: ref. 36, Springer Nature Ltd (a); ref. 40, Springer Nature Ltd (b); ref. 41, Springer Nature Ltd (c); ref. 44, Springer 
Nature Ltd (d); ref. 45, Springer Nature Ltd (e). Illustrations adapted with permission from: ref. 98, Springer Nature Ltd (b); ref. 41, Springer Nature  
Ltd (c); ref. 99, Springer Nature Ltd (e).
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size constraint is overcome by the development of a perfused vas-
culature that enables the convective transport of nutrients and gases 
throughout the organ. To solve the problem of insufficient nutrient 
and gas supply, some studies have cultured organoids in suspen-
sion under continuous agitation or in spinning bioreactors65,66. One 
important issue when envisioning strategies for organoid vascular-
ization is how to generate organ-specific endothelial cells that can 
properly organize and assemble to form organ-specific vasculature 
supporting organoid function. Remarkably, human blood vessel 
organoids have been recently derived from hPSCs67, but the role 
of specific inductive cues for later specification and differentiation 
into organ-specific endothelial cells needs further research. The 
gene regulatory networks that control endothelial cell specification 
in mouse brain, liver, lung and kidney has recently been described68. 
This information will be crucial when defining new approaches for 
the generation of organ-specific endothelial cells to be supplemented 
or endogenously generated in developing organoids. As a starting 
point, researchers have approached hPSC-organoid vascularization 
through the introduction of endothelial cells69 or using proangio-
genic factors during the differentiation process70. Nevertheless, only 
a few studies have added support cells (that is, pericytes, smooth 
muscle cells or a stromal component71).
In  vivo vascularization (host-derived vascularization) of either 
hPSC-derived cerebral organoids72, liver buds73,74 or kidney organ-
oids75 has been partially achieved after organoid transplantation 
into immunodeficient mice. In a different approach, hPSC-derived 
kidney organoids have been engrafted onto the chick CAM show-
ing host vascularization, but also the formation of capillary loop 
stage glomeruli-like structures with endothelial cells of human 
origin in close contact to podocyte-like cells40 (Fig. 4a). Altogether, 
these findings indicate that the formation of functional vascular 
networks upon transplantation possibly require a synergistic 
modulation of the microenvironment together with the forma-
tion of the proper interactions between the host vasculature and 
the endothelial-committed cells (pre-)existing in the engrafted 
hPSC-derived organoids. This last point will probably prove to be 
both necessary and highly challenging in endodermal and ectoder-
mal hPSC-derived organoids, where the endogenous formation of 
alternative mesenchymal fates (that is, endothelial cells) during the 
onset of differentiation is scarce or totally missing.
The use of microfluidic systems to engineer vascularization 
represents an alternative to in vivo transplantation methodologies. 
In vitro microvasculature is being created by encapsulating endothe-
lial cells within a hydrogel introduced into a microfluidic device that 
self-assemble into perfusable vascular networks. This approach has 
been further explored to create models for the blood-brain barrier76 
(Fig.  4b), tumour angiogenesis77 and tumour cell extravasation78. 
Interestingly, in a recent study a 3D-printed millimetre-size cham-
ber was designed to culture hPSC-derived kidney organoids under 
constant flow. This approach sufficed for the expansion of endothe-
lial progenitors within the organoids leading to a higher degree of 
vascularization compared to the static culture conditions79. Another 
possibility to create vascular networks is through the fabrication 
of perfusable channels by 3D bioprinting, as recently developed 
through the combination of EBs containing iPSC-derived cardiac 
myoblasts and cardiac fibroblasts with a sacrificial 3D-printed vas-
cular network80. The fabrication of the final construct through this 
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Fig. 3 | Integrating emergent technologies for understanding tissue 
morphogenesis. Single-cell transcriptomics techniques allow for 
high-resolution analysis of organoids heterogeneity and similarity to in vivo 
counterparts. Complimentary technologies as in situ sequencing and high 
multiplex imaging mass cytometry are being developed to associate cell 
positional information to cellular signatures. In parallel, the field of cell 
and tissue mechanics is developing new tools for probing 3D organoid 
mechanics coupled to robust computational models to further predict 
how cell-generated forces can shape organoids. In the near future, recent 
advances in multiplex measurements of mechanical and biochemical 
cellular signatures across a range of spatial, temporal and functional 
scales or in response to different environmental or genetic perturbations 
would precisely define organoid dynamics during hPSC organoid 
differentiation would offer an unprecedented scenario for investigating 
human development and disease. Illustrations for cell and tissue scale 
measurements reproduced with permission from ref. 59, Springer Nature Ltd.
Box 2 | Techniques for probing organoids mechanical properties
There are several techniques to probe cell and tissue mechanical 
forces, but their applicability is mostly restricted to single cells 
and monolayers in vivo and in vitro105. Recently, some of them 




 encoded Förster resonance energy transfer 
sensors. This promising approach measures tension at specific 
molecules within adhesion sites or in the cytoskeleton106. These 
sensors are easy to (over)express and they provide molecular 
scale information. They do not provide directional information 
and their relatively low signal-to-noise ratio restricts applicability 
in 3D multicellular systems.
3D traction force microscopy. It maps traction stresses at 
the interface between a cell and its surrounding ECM in 3D, 
computing the cell-induced deformation of the ECM107. Major 
limitations include the complexity of the used algorithms and 
the fact that the ECM properties must be known.
Insertion of cell-size soft droplets into the tissue. Because 
the mechanical properties of these inserted droplets are known, 
they can provide reliable measurements of physiological stress108. 
Its application is limited by the difficulty of micro-injecting the 
droplets into the organoid.
Laser ablation. A high-power laser pulse is used to ablate 
cellular structures and force is then computed from the resulting 
recoil of the tissue surrounding the ablation area109. This approach 
can be readily translated to organoids. It is an invasive technique 
and, therefore, is not suitable to measure the time evolution of 
forces.
Optical force inference technologies. They generate 
high-resolution imaging of cells and use force balance arguments 
and assumptions of material properties to infer the forces 
that cause a given change in shape110. They have an enormous 
potential to unveil the mechanical state of an organoid as it 
acquires a certain shape.
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to that found in living tissue (~200 million cells per ml) with mac-
roscopic dimensions80. While the vascular diameters remained large 
compared to natural capillaries, the network could be patterned 
to replicate those of specific organs, as recently shown for heart81 
(Fig. 4b). Another technical challenge, regardless of the approach 
used to induce vascularization, is to achieve stable and mature 
microvascular networks within organoids, meaning that the con-
structed vascular network should remain stable in time and have 
the proper composition and morphology of the native vasculature, 
even after removal of the stimuli used to induce vascularization. 
Overall, these bioengineering approaches could provide vasculature 
to organoids and offer control over nutrient/gas delivery and waste 
removal. This last point is of extremely importance when aiming to 
increase organoid lifespan, size and complexity compared to cur-
rent static culture systems.
Engineering tissue-tissue interactions. During development, the 
shape of organs is regulated by biochemical and biophysical signals 
from adjacent developing tissues. These complex tissue-tissue inter-
actions in vitro can be mimicked through spatial pre-patterning of 
organoids and through a variety of 3D co-culture approaches. The 
group of Ryuichi Nishinakamura has pioneered the generation of 
mouse PSC-derived ureteric bud progenitor cells and nephron pro-
genitor cells, that were further manually assembled together with 
isolated mouse stromal cells generating kidney organoids mimick-
ing the organotypic architecture of the embryonic kidney71. In the 
future, integrating native or PSC-derived branching epithelium 
into developing kidney organoids in the presence of stromal cells 
through 3D bioprinting may represent an affordable approach 
to precise positioning of these different components, so that the 
branching epithelium can act as an organizer of tissue geometry 
during kidney organoid differentiation. In a similar approach, using 
distinct committed cell progenitors as a starting point, Takebe and 
colleagues achieved the derivation of liver buds73,74. Other organoid 
systems that may benefit from the application of 3D bioprinting are 
those needing the interaction of cells coming from different embry-
onic lineages. A recent example is the generation of intestinal tis-
sues with a functional enteric nervous system82 (Fig. 5). In another 
elegant study, Birey and colleagues have mimicked brain interre-
gional interactions by in vitro 3D assembling pre-differentiated dor-
sal and ventral forebrain spheroids from hPSCs referred as ‘brain 
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Blood–brain barrier on a chip
Vasculature by design
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Day 8
Fig. 4 | Strategies for engineering hPSC-derived organoids vascularization. a, Different in vivo transplantation approaches have been developed to 
incorporate vascular supply to hPSC organoids. Liver buds were transplanted into the cranial window of immunodeficient mice showing perfusion of human 
blood vessels connected to the host vasculature. A similar strategy has allowed vascularization of brain organoids that after 14 days of implantation into the 
adult mouse brain cortex, leading to enhanced neuronal activity in the absence of necrosis. In a different approach, the chick chorioallantoic membrane was 
used to engraft kidney organoids, which further differentiated showing a better organization of endogenous endothelial cells in close vicinity to podocyte-like 
cells, similar to in vivo early-stage capillary loop formation in the maturing glomeruli. b, Bioengineering approaches have been explored for organoid 
vascularization. The use of microfluidics allowed the generation of self-organized 3D vascular networks, proving the feasibility of this approach for emulating 
blood–brain barrier OoC from hPSCs. In another approach, a millimetre-size fluidic device was fabricated to culture kidney organoids under high fluid 
shear stress that substantially enhanced the formation of vascular structures composed of endothelial cells endogenously derived during kidney organoid 
differentiation. Recently, 3D bioprinting was used to generate vascularized heart patches from hPSCs. Figure reproduced with permission from: ref. 74, Elsevier 
(a, vascularized liver bud images); ref. 72, Springer Nature Ltd (a, vascularized brain organoid images); ref. 40, Springer Nature Ltd (a, vascularized kidney 
organoid images); ref. 76, Elsevier (b, 3D self-organized blood–brain barrier model image); ref. 79, Springer Nature Ltd (b, vascularized kidney organoid image); 
ref. 81, Wiley (b, bioprinting tissue scale vasculature image).
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interneurons observed in the fetal forebrain83. Importantly, this 
functional characteristic was abnormal when a neurodevelopmental 
disorder called Timothy syndrome was modelled using this assemb-
loid system83. Following a similar approach, Takebe and colleagues 
recapitulated the human hepato-biliary-pancreatic tissue-tissue 
boundaries in vitro84 (Fig. 5).
Overall, these methodologies will require further optimization 
to achieve proper cells-to-organoid and organoid-to-organoid inte-
gration with the capability to recapitulate in vivo development and 
growth into higher complex and functional tissue structures.
Engineering physiological-like environments. Physico-chemical stim-
uli from systemic origin (that is, electrical stimuli, tissue strain and 
compression, fluid flow) are known to cooperatively participate to 
drive organ and tissue morphogenesis, maturation, and homeo-
stasis. Microengineered devices mimicking physiological micro-
environments have been exploited to create miniaturized cellular 
models, so called organ-on-a-chip (OoC), that can theoretically 
capture key aspects of (human) organ physiology. This technology 
holds the promise to recreate rather simple (2D), but dynamic phys-
iological microenvironments. The recent adaptation of microfluidic 
devices to incorporate 3D cultures have accelerated their applica-
tion for organoid research to harness tissue–tissue interactions and 
further organoid differentiation and maturation. Seminal studies 
have simulated the interaction of two-organ systems by using inte-
grated tissue chambers, including gastrointestinal tract epithelium 
and liver cells to mimic liver injury85 or the interaction of human 
pancreatic islets and liver spheroids to recreate a type 2 diabetes 
model86. Another work designed a compartmentalized unit from 
hPSCs that consisted of a motor neuron spheroid activating con-
tractile muscle in a model of amyotrophic lateral sclerosis (ALS)87. 
More recently, hPSC-derived retinal pigmented epithelial cells were 
assembled in close contact to hPSC-derived optic cup organoids in a 
multilayered OoC device proving the feasibility of this approach for 
drug toxicity screenings88 (Fig. 5). Moreover, by supporting physi-
ological flow rates OoC have improved the growth and differentia-
tion characteristics of hPSC-derived pancreatic islets89, intestinal90, 
stomach91 and liver92 organoids.
Overall, these studies highlight the utility of the OoC technol-
ogy to recreate tissue-tissue crosstalk and show the potential for 
advanced in vitro platforms for pharmacological testing. Also, cou-
pling OoC systems may increase our understanding of complex 
inter-organ (that is, body-on-a-chip) behaviour in health versus 
disease. In the future, these connections might be accomplished via 
a self-assembled vascular network, thus enabling a more physiologi-
cal context.
Engineering ethics for hPSC-derived organoids
Despite the recent advent of human organoid research, several per-
tinent ethical issues have already been identified by the research 
ethics and scientific literature. Among these are the informed con-
sent requirements for ethically acceptable procurement of human 
cells necessary to generate organoids, the biobanking and transfer 
of patient-specific organoids for research, the impact of organoid 
technology on animal research and clinical trials, and the poten-
tial role of organoids in personalized medicine93,94. Much overlap 
Organoid by design
Innervated gut organoid
Retina on a chip
Brain assembloid
Hepato-biliary-
pancreatic assembloid Patient motor 
unit on a chip
Liver buds
Day 1–7





Fig. 5 | Approaches for engineering tissue–tissue interactions. Forcing cell-to-cell contact by co-culturing in three dimensions in different combinations 
of cells and cell spheroids from hPSCs results in the self-assembly of complex 3D structures. These approaches can guide the formation of higher-grade 
organoids in terms of cellular, morphological and functional complexity, mimicking in vivo tissue–tissue interactions. The adaptation of microfluidic designs 
to organoid culture requirements has proved successful when fabricating OoCs suitable for drug screening and disease modelling applications. Figure 
reproduced with permission from: ref. 82, Springer Nature Ltd (innervated gut organoid image); ref. 73, Springer Nature Ltd (live buds image); ref. 88 eLife 
Sciences (retina on a chip image) ; ref. 83, Springer Nature Ltd (brain assembloid image); ref. 84, Springer Nature Ltd (Hepato-biliary-pancreatic assembloid 
image); ref. 87, AAAS (patient motor unit on a chip image).
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exists between these and ethical issues surrounding other forms of 
biomedical research using cell lines and biospecimens. However, as 
engineers and stem cell biologists seek further opportunities to col-
laborate in organoid mechanics, there is a need to develop a new 
variant of traditional research ethics, that might be termed bioen-
gineering ethics95.
Modelled after the ethics of design engineering pioneered by 
Dutch scholars, bioengineering ethics could emerge as a new dis-
cipline, characterized by encouraging ethicists and scientists to 
discuss the ethical choices and value trade-offs that drive research 
decisions during the design phase of experiments96. This approach 
recognizes that organoid bioengineering, like all other forms of 
engineering, is not a value-neutral activity. Bioengineering ethics 
calls for the integration of both bioengineering and ethics, so that 
ethicists and bioengineers can act as co-designers of research trajec-
tories and choices made at the bench side, with each party inform-
ing the other, thus helping to infuse ethical reflection upstream 
during the development phases of new organoid projects.
Promoting this co-evolution of bioengineering ethics, however, 
will require high-level attention and dedicated resources from 
departments, universities and funding agencies97. Multi-level insti-
tutional mechanisms and incentives are needed to make such collab-
orations possible if ethicists and bioengineers are to be empowered 
to work together during the lifecycle of organoid research projects. 
For example, universities and funding agencies should allocate time 
and resources to enable ethicists, researchers and trainees to col-
laborate in the manner that bioengineering ethics demands, and to 
reward their efforts by establishing norms and financial structures 
that recognize their mutually supportive work. These challenges, 
though difficult, are tractable. Attention to these issues will foster 
a productive and responsible partnership between the disciplines of 
bioengineering and human organoid research.
Future directions for hPSC-derived organoids engineering
Despite the rapid progress in the field of organoid engineer-
ing the community is facing long term challenges as the absence 
of experimental and conceptual access to organoid mechanics. 
Coupled to the development of designer matrices with fine tun-
able and controlled biophysical properties all these developments 
will be essential to provide the proper physiological signals to 
drive stem cell self-organization and patterning without restrict-
ing later morphogenesis events38. On the other hand, the appli-
cation of transcriptomics will reveal the complexity of cell types 
produced in organoids, the proportion of a specific cell popula-
tion with respect to the others, as well as their differentiation state 
and spatial distribution. All this information will ultimately help 
to improve the efficacy, reproducibility and robustness of current 
hPSC-organoid differentiation procedures. Moreover, the defini-
tion of suitable scaling-up principles to maintain absolute val-
ues of physiological parameters and proper relative proportions 
between different types of cells within organoids may help to bet-
ter mimic in vivo physiological conditions. Enhancing control over 
multiple tissue–tissue interactions when interrogating organ-like 
biological functions under homeostasis and disease-like condi-
tions will ultimately support the application of hPSC-organoid 
technology for a new era in personalized and precise medicine 
applications.
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